Cargando…

Dehydrocorydaline inhibits cell proliferation, migration and invasion via suppressing MEK1/2-ERK1/2 cascade in melanoma

Purpose: Alkaloids are naturally occurring chemical compounds that are widely distributed in plants, and have pharmaceutical values and low toxicity. In recent years, some of them have been demonstrated to be promising therapeutic drug candidates for cancer treatment. Herein, we tried to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Huanrong, Dong, Zhen, Wang, Xianxing, Bai, Longchang, Lei, Qian, Yang, Jie, Li, Lin, Li, Qian, Liu, Lichao, Zhang, Yanli, Ji, Yacong, Guo, Leiyang, Liu, Yaling, Cui, Hongjuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620435/ https://www.ncbi.nlm.nih.gov/pubmed/31456643 http://dx.doi.org/10.2147/OTT.S183558

Ejemplares similares

Dehydrocorydaline Inhibits Cell Proliferation, Migration and Invasion via Suppressing MEK1/2-ERK1/2 Cascade in Melanoma [Corrigendum]
Publicado: (2021)

Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma
por: Liu, Lichao, et al.
Publicado: (2017)

ZC3H15 Correlates with a Poor Prognosis and Tumor Progression in Melanoma
por: Li, Qian, et al.
Publicado: (2021)

Dihydrocapsaicin Inhibits Cell Proliferation and Metastasis in Melanoma via Down-regulating β-Catenin Pathway
por: Shi, Shaomin, et al.
Publicado: (2021)

Corrigendum: Dihydrocapsaicin inhibits cell proliferation and metastasis in melanoma via down-regulating β-catenin pathway
por: Shi, Shaomin, et al.
Publicado: (2022)

CSN6 promotes melanoma proliferation and metastasis by controlling the UBR5-mediated ubiquitination and degradation of CDK9
por: Zhang, Yanli, et al.
Publicado: (2021)

Tubeimoside I Inhibits Cell Proliferation and Induces a Partly Disrupted and Cytoprotective Autophagy Through Rapidly Hyperactivation of MEK1/2-ERK1/2 Cascade via Promoting PTP1B in Melanoma
por: Du, Juan, et al.
Publicado: (2020)

Antibiotic drug tigecycline inhibits melanoma progression and metastasis in a p21CIP1/Waf1-dependent manner
por: Hu, Huanrong, et al.
Publicado: (2015)

Morusin shows potent antitumor activity for melanoma through apoptosis induction and proliferation inhibition
por: Liu, Wei, et al.
Publicado: (2023)

LC-MS/MS Determination and Pharmacokinetic Study of Dehydrocorydaline in Rat Plasma after Oral Administration of Dehydrocorydaline and Corydalis yanhusuo Extract
por: Li, Qiu-Yue, et al.
Publicado: (2014)

Dehydrocorydaline attenuates bone cancer pain by shifting microglial M1/M2 polarization toward the M2 phenotype
por: Huo, Wenwen, et al.
Publicado: (2018)

Direct Targeting of the Raf-MEK-ERK Signaling Cascade Inhibits Neuroblastoma Growth
por: Chilamakuri, Rameswari, et al.
Publicado: (2022)

Navigating the ERK1/2 MAPK Cascade
por: Martin-Vega, Ana, et al.
Publicado: (2023)

UBTF facilitates melanoma progression via modulating MEK1/2-ERK1/2 signalling pathways by promoting GIT1 transcription
por: Zhang, Jian, et al.
Publicado: (2021)

Quantifying ERK activity in response to inhibition of the BRAFV600E-MEK-ERK cascade using mathematical modelling
por: Hamis, Sara J., et al.
Publicado: (2021)

The D Domain of LRRC4 anchors ERK1/2 in the cytoplasm and competitively inhibits MEK/ERK activation in glioma cells
por: Wang, Zeyou, et al.
Publicado: (2016)

Effect of Wine and Vinegar Processing of Rhizoma Corydalis on the Tissue Distribution of Tetrahydropalmatine, Protopine and Dehydrocorydaline in Rats
por: Dou, Zhiying, et al.
Publicado: (2012)

Dehydrocorydaline Accounts the Majority of Anti-Inflammatory Property of Corydalis Rhizoma in Cultured Macrophage
por: Kong, Xiangpeng, et al.
Publicado: (2020)

Dehydrocorydaline promotes myogenic differentiation via p38 MAPK activation
por: Yoo, Miran, et al.
Publicado: (2016)

Dehydrocorydaline inhibits the tumorigenesis of breast cancer MDA-MB-231 cells
por: Huang, Ying, et al.
Publicado: (2020)

Antiatherosclerotic effect of dehydrocorydaline on ApoE(−/−) mice: inhibition of macrophage inflammation
por: Wen, Bin, et al.
Publicado: (2021)

Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells
por: Zhao, Yuzu, et al.
Publicado: (2017)

Deregulation of Hepatic Mek1/2–Erk1/2 Signaling Module in Iron Overload Conditions
por: Tangudu, Naveen Kumar, et al.
Publicado: (2019)

The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation
por: Zhang, Nianzhu, et al.
Publicado: (2016)

The Effect of Arrestin Conformation on the Recruitment of c-Raf1, MEK1, and ERK1/2 Activation
por: Coffa, Sergio, et al.
Publicado: (2011)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2010)

Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway
por: Cai, Jun, et al.
Publicado: (2009)

MEK inhibition induces apoptosis in osteosarcoma cells with constitutive ERK1/2 phosphorylation
por: Baranski, Zuzanna, et al.
Publicado: (2015)

Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways
por: Vesely, David L.
Publicado: (2011)

The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control
por: Guégan, Jean-Philippe, et al.
Publicado: (2012)

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling
por: Tripathi, Rakshamani, et al.
Publicado: (2020)

Antinociceptive effects of dehydrocorydaline in mouse models of inflammatory pain involve the opioid receptor and inflammatory cytokines
por: Yin, Zhi-Yu, et al.
Publicado: (2016)

MEK1/2 Inhibitor (GDC0623) Promotes Osteogenic Differentiation of Primary Osteoblasts Inhibited by IL-1β through the MEK-Erk1/2 and Jak/Stat3 Pathways
por: Zhang, Zeng-Qiao, et al.
Publicado: (2021)

Galangin ameliorates cardiac remodeling via the MEK1/2–ERK1/2 and PI3K–AKT pathways
por: Wang, Hui‐Bo, et al.
Publicado: (2019)

Rapamycin Inhibits Cardiac Hypertrophy by Promoting Autophagy via the MEK/ERK/Beclin-1 Pathway
por: Gu, Jun, et al.
Publicado: (2016)

FLOT2 Promotes the Proliferation and Epithelial-mesenchymal Transition of Cervical Cancer by Activating the MEK/ERK1/2 Pathway
por: Li, Yang, et al.
Publicado: (2022)

The role and mechanism of NLRP3 inflammasome-mediated astrocyte activation in dehydrocorydaline against CUMS-induced depression
por: Fang, Yu, et al.
Publicado: (2022)

Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers
por: Ozkan-Dagliyan, Irem, et al.
Publicado: (2020)

Protein phosphatase 6 regulates trametinib sensitivity, a mitogen-activated protein kinase kinase (MEK) inhibitor, by regulating MEK1/2-ERK1/2 signaling in canine melanoma cells
por: YAMAMOTO, Miu, et al.
Publicado: (2023)

PADI2‐Catalyzed MEK1 Citrullination Activates ERK1/2 and Promotes IGF2BP1‐Mediated SOX2 mRNA Stability in Endometrial Cancer
por: Xue, Teng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3hjfapms651kdqrcaj5t6tm3a